Objectives:To determine the in vivo dose-response relation between administered 5-aminolevulinic acid (ALA) and the concentration of protoporphyrin IX (PpIX) produced in rat uterine tissue, to determine the effect of estrogen on ALA-induced PpIX production in the rat endometrium and myometrium, and to determine the selectivity of ALA-induced PpIX production in uterine tissue.
Methods:Ovary-intact female rats (n = 53) received a subcutaneous estradiol-17β (E2) implant. Three days later, ALA dissolved in saline (0, 1, 2.5, 10, 25, or 50 mg/100 μL) was injected into one uterine horn. Three hours after ALA administration, the uterus was removed and the endometrium was scraped from the myometrium. In a second study, rats (n = 35) were ovariectomized and 8 days later given either an E2 or sham implant. After 3 days of hormonal or sham priming, ALA (10 or 25 mg) was injected into the uterine horn 3 hours before hysterectomy. In both studies, PpIX was extracted in a methanol/perchloric acid (1:1) solution and quantified spectrofluorometrically.
Results:Five-aminolevulinic acid increased PpIX concentrations in the endometrium and myometrium in a dose-dependent fashion. Twenty-five milligrams of LA produced maximum PpIX concentrations in both the endometrium and myometrium. In the second study, sham-implanted ovariectomized rats had endometrial PpIX concentrations approximately two times higher than those in the estrogen-primed rats after doses of either 10 or 25 mg ALA. In the third study, the endometrium had two to three times higher PpIX concentrations than the myometrium at 1, 10, 25, and 50 mg of ALA.
Conclusions:In in vivo dose-response relation was demonstrated between ALA and uterine production of PpIX, with maximum PpIX concentrations occurring after 25 mg of intrauterine ALA. Because estrogen was not required to convert ALA to PpIX, complete endomentrial ablation may best be achieved with an unstimulated endometrium.
1. Wyss P, Tromberg BJ, Wyss MT, et al. Photodynamic destruction of endometrial tiisue with topical 5-aminolevulinic acid in rats and rabbits. Am J Obstet Gynecol1994;171:1176-1183.
2.
2. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium. Photochem Photobiol1993;57:803-807.
3.
3. Yang JZ, Van Vugt DA, Roy BN, Kennedy JC, Foster WG, Reid RL. Intrauterine 5-aminolevulinic acid induces selective endometrial fluorescence in the Rhesus monkey and Cynomolgus monkey. J Soc Gynecol Invest1996;3:152-157.
4.
4. Gannon MJ, Johnson N, Roberts DJH, et al. Photosensitization of the endometrium with topical 5-aminolevulinic acid. Am J Obster Gynecol1995;173:1826-1828.
5.
5. Yang JZ, Van Vugt DA, Melchoir MF, Hahn P, Reid RL. Photodynamic ablation of early pregnancy in the rat with 5-aminolevulinic acid: A potential new therapy for tubal ectopic pregnancy in the human. Fertil Steril1994;62:1060-1065.
6.
6. Stott PC. The outcome of menorrhagia: A retrospective case control study. J R Coll Gen Pract1983;33:715-720.
7.
7. Pokras R, Hufnagel VG. Hysterectomy in the United States. Am J Public Health1988;78:852-853.
8.
8. Jamieson MA, Reid RL. Compliance with menopausal hormone replacement therapy. In: Lorrain J, ed. Modern management and treatment of menopause and osteoporosis. 2nd ed.Montreal: Les Presses de l'Universite de Montreal, 1995:622-627.
9.
9. Hahn RG. Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors. Am J Obstet Gynecol1989;161:1854-1858.
10.
10. Henderson BW, Dougherty TJ. How does photodynamic therapy work?Photochem Photobiol1992;55:145-157.
11.
11. Batlle AMd. Porphyrins, porphyrias, cancer and photodynamic therapy—a model for carcinogenesis. J Photochem Photobiol1993;20:5-22.
12.
12. Kennedy JC, Pottier RH. Endogeneous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol1992;14:275-292.
13.
13. Ash DV, Brown SB. New drugs and future developments in photodynamic therapy. Eur J Cancer1993;29A:1781-1783.
15. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br J Cancer1993;68:41-51.
16.
16. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Evidence of lasting functional destruction of the rat endometrium after 5-aminolevulinic acid-induced photodynamic ablation: Prevention of implantation. Am J Obstet Gynecol1993;168:995-1001.
17.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem1951; 193:265-275.
18.
18. MacRobert AJ, Bown SG, Philips D.What are the ideal photoproperties for a sensitizer? In: Bock G, Harnett S, eds. Photosensitizing compounds: Their chemistry, biology and clinical use. Toronto: John Wiley and Sons, 1989:4-16.
19.
19. Pottier RH, Chow YFA, LaPlante J-P, Truscott G, Kennedy JC, Beiner LA. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol1986;44:679-687.
20.
20. Rossi F, Campbell D, Pottier RH, Kennedy JC, Dickson EF. In vitro studies on the potential use of 5-aminolevulinic acidmediated photodynamic therapy for gynecologic tumors. Br J Cancer1996;74:881-887.
21.
21. Judd MD, Bedwell J, MacRobert AJ, Bown SG. Comparison of the distribution of phthalocyanine and ALA-induced porphyrin sensitisers within the rabbit uterus. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic therapy and biomedical lasers. New York: Elsevier Science Publishers, 1992:322-326.
22.
22. Iinuma S, Farshi SS, Ortel B, Hasan T.A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer1994;70:21-28.
23.
23. Wyss P, Svaasand LO, Tadir Y, et al. Photomedicine of the endometrium: Experimental concepts. Hum Reprod1995;10:221-226.
24.
24. Lin MC, Gosink BB, Wolf SI, et al. Endometrial thickness after menopause: Effect of hormonal replacement. Radiology1991;180:427-432.
25.
25. Steinbach P, Weingandt H, Baumgartner R, Kriegmair M, Hofstadter F, Knuchel R.Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 4-aminolevulinic acid. Photochem Photobiol1995;62:887-895.
26.
26. Fukuda H, Batlle AMd, Riley PA. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to 5-aminolevulinic acid. Int J Biochem1993;25:1407-1410.
27.
27. Goldrath MH, Fuller TA, Segal S.Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol1981;140:14-19.
28.
28. Lomano JM. Dragging technique versus blanching technique for endometrial ablation with the Nd: YAG laser in the treatment of chronic menorrhagia. Am J Obstet Gynecol1988;159:152-155.
